111 related articles for article (PubMed ID: 36872079)
21. Basal neutrophil-to-lymphocyte ratio is associated with overall survival in melanoma.
Lino-Silva LS; Salcedo-Hernández RA; García-Pérez L; Meneses-García A; Zepeda-Najar C
Melanoma Res; 2017 Apr; 27(2):140-144. PubMed ID: 28125448
[TBL] [Abstract][Full Text] [Related]
22. Metallothionein-overexpression as a prognostic factor for progression and survival in melanoma. A prospective study on 520 patients.
Weinlich G; Bitterlich W; Mayr V; Fritsch PO; Zelger B
Br J Dermatol; 2003 Sep; 149(3):535-41. PubMed ID: 14510986
[TBL] [Abstract][Full Text] [Related]
23. Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial.
Schmidt H; Suciu S; Punt CJ; Gore M; Kruit W; Patel P; Lienard D; von der Maase H; Eggermont AM; Keilholz U; ;
J Clin Oncol; 2007 Apr; 25(12):1562-9. PubMed ID: 17443000
[TBL] [Abstract][Full Text] [Related]
24. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
Song A; Eo W; Lee S
World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
[TBL] [Abstract][Full Text] [Related]
25. Predictive impact of the inflammation-based indices in uveal melanoma liver metastases treated with transarterial hepatic chemoperfusion.
Ludwig JM; Haubold J; Bauer S; Richly H; Siveke JT; Wimmer J; Umutlu L; Schaarschmidt BM; Theysohn JM
Radiol Oncol; 2021 May; 55(3):347-353. PubMed ID: 34051707
[TBL] [Abstract][Full Text] [Related]
26. Prognostic role of elevated preoperative systemic inflammatory markers in localized soft tissue sarcoma.
Li Y; Liu X; Zhang J; Yao W
Cancer Biomark; 2016; 16(3):333-42. PubMed ID: 26835589
[TBL] [Abstract][Full Text] [Related]
27. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.
Murali R; Haydu LE; Long GV; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Kefford RF; Thompson JF; Scolyer RA
Ann Surg Oncol; 2012 Jun; 19(6):1782-9. PubMed ID: 22350600
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness of four inflammatory markers in predicting prognosis in 2374 women with breast cancer.
Wariss BR; de Souza Abrahão K; de Aguiar SS; Bergmann A; Thuler LCS
Maturitas; 2017 Jul; 101():51-56. PubMed ID: 28539169
[TBL] [Abstract][Full Text] [Related]
29. Association of a Proposed New Staging System for Folliculotropic Mycosis Fungoides With Prognostic Variables in a US Cohort.
Charli-Joseph Y; Kashani-Sabet M; McCalmont TH; Kornak J; Allen I; Ai WZ; LeBoit PE; Pincus LB
JAMA Dermatol; 2021 Feb; 157(2):157-165. PubMed ID: 33295938
[TBL] [Abstract][Full Text] [Related]
30. Expression of microRNA-106b and its clinical significance in cutaneous melanoma.
Lin N; Zhou Y; Lian X; Tu Y
Genet Mol Res; 2015 Dec; 14(4):16379-85. PubMed ID: 26662433
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio in follicular lymphoma: a retrospective cohort study.
Lee SF; Luque-Fernandez MA
BMJ Open; 2017 Nov; 7(11):e017904. PubMed ID: 29101140
[TBL] [Abstract][Full Text] [Related]
32. Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: a nationwide population-based study in Sweden.
Eriksson H; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Ingvar C; Lindholm C; Naredi P; Stierner U; Wagenius G; Carstensen J; Hansson J
Eur J Cancer; 2013 Aug; 49(12):2705-16. PubMed ID: 23583439
[TBL] [Abstract][Full Text] [Related]
33. Risk Factors for Lymphatic and Hematogenous Dissemination in Patients With Stages I to II Cutaneous Melanoma.
Calomarde-Rees L; García-Calatayud R; Requena Caballero C; Manrique-Silva E; Traves V; García-Casado Z; Soriano V; Kumar R; Nagore E
JAMA Dermatol; 2019 Jun; 155(6):679-687. PubMed ID: 31042264
[TBL] [Abstract][Full Text] [Related]
34. Clinical implications of systemic inflammatory response markers as independent prognostic factors for advanced pancreatic cancer.
Qi Q; Geng Y; Sun M; Wang P; Chen Z
Pancreatology; 2015; 15(2):145-50. PubMed ID: 25641673
[TBL] [Abstract][Full Text] [Related]
35. Monocyte-to-lymphocyte ratio as a prognostic factor in peripheral whole blood samples of colorectal cancer patients.
Jakubowska K; Koda M; Grudzińska M; Kańczuga-Koda L; Famulski W
World J Gastroenterol; 2020 Aug; 26(31):4639-4655. PubMed ID: 32884222
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of pretreatment neutrophil-to-lymphocyte ratio in melanoma patients: A meta-analysis.
Zhan H; Ma JY; Jian QC
Clin Chim Acta; 2018 Sep; 484():136-140. PubMed ID: 29856976
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care.
Heppt MV; Siepmann T; Engel J; Schubert-Fritschle G; Eckel R; Mirlach L; Kirchner T; Jung A; Gesierich A; Ruzicka T; Flaig MJ; Berking C
BMC Cancer; 2017 Aug; 17(1):536. PubMed ID: 28797232
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of ulceration varies across Breslow thicknesses and clinical stages in acral melanoma: a retrospective study.
Wei X; Wu D; Chen Y; Li H; Zhang R; Yao H; Chi Z; Cui C; Bai X; Mao L; Qi Z; Li K; Lan S; Chen L; Guo R; Yao X; Lian B; Kong Y; Dai J; Tang B; Wang X; Guo J; Si L
Br J Dermatol; 2022 Jun; 186(6):977-987. PubMed ID: 35042273
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy.
Lee S; Oh SY; Kim SH; Lee JH; Kim MC; Kim KH; Kim HJ
BMC Cancer; 2013 Jul; 13():350. PubMed ID: 23876227
[TBL] [Abstract][Full Text] [Related]
40. Prognostic utility of the combination of monocyte-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with NSTEMI after primary percutaneous coronary intervention: a retrospective cohort study.
Fan Z; Li Y; Ji H; Jian X
BMJ Open; 2018 Oct; 8(10):e023459. PubMed ID: 30341133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
